Integral Diagnostics Ltd (IDX) - Total Liabilities
Based on the latest financial reports, Integral Diagnostics Ltd (IDX) has total liabilities worth AU$732.53 Million AUD (≈ $518.31 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Integral Diagnostics Ltd (IDX) investment intensity to see how much of total assets are deployed in long-term investments.
Integral Diagnostics Ltd - Total Liabilities Trend (2012–2025)
This chart illustrates how Integral Diagnostics Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see IDX current and non-current assets.
Integral Diagnostics Ltd Competitors by Total Liabilities
The table below lists competitors of Integral Diagnostics Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sansec Technology Co. Ltd. A
SHG:688489
|
China | CN¥218.65 Million |
|
Beijing Tianyishangjia New Material Corp Ltd
SHG:688033
|
China | CN¥2.41 Billion |
|
Dook Media Group Limited
SHE:301025
|
China | CN¥86.67 Million |
|
AAEON Technology Inc
TW:6579
|
Taiwan | NT$3.71 Billion |
|
Tianshui Zhongxing Bio-technology Co Ltd
SHE:002772
|
China | CN¥4.18 Billion |
|
Krishana Phoschem Limited
NSE:KRISHANA
|
India | Rs-5.61 Billion |
|
CytomX Therapeutics Inc
NASDAQ:CTMX
|
USA | $79.16 Million |
|
Gansu Engineering Consulting Group Co Ltd
SHE:000779
|
China | CN¥1.31 Billion |
Liability Composition Analysis (2012–2025)
This chart breaks down Integral Diagnostics Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See IDX equity financing ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.68 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Integral Diagnostics Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Integral Diagnostics Ltd (2012–2025)
The table below shows the annual total liabilities of Integral Diagnostics Ltd from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | AU$732.53 Million ≈ $518.31 Million |
+65.52% |
| 2024-06-30 | AU$442.57 Million ≈ $313.15 Million |
-5.02% |
| 2023-06-30 | AU$465.96 Million ≈ $329.70 Million |
+6.93% |
| 2022-06-30 | AU$435.77 Million ≈ $308.34 Million |
+8.90% |
| 2021-06-30 | AU$400.16 Million ≈ $283.14 Million |
+11.60% |
| 2020-06-30 | AU$358.58 Million ≈ $253.72 Million |
+91.30% |
| 2019-06-30 | AU$187.45 Million ≈ $132.63 Million |
+83.57% |
| 2018-06-30 | AU$102.11 Million ≈ $72.25 Million |
+2.08% |
| 2017-06-30 | AU$100.03 Million ≈ $70.78 Million |
+2.93% |
| 2016-06-30 | AU$97.19 Million ≈ $68.76 Million |
-14.90% |
| 2015-06-30 | AU$114.20 Million ≈ $80.80 Million |
+2038.51% |
| 2014-06-30 | AU$5.34 Million ≈ $3.78 Million |
+4854461.82% |
| 2013-06-30 | AU$110.00 ≈ $77.83 |
-99.98% |
| 2012-06-30 | AU$501.00K ≈ $354.49K |
-- |
About Integral Diagnostics Ltd
Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. The company offers magnetic resonance imaging, positron emission tomography, computed tomography mammography, interventional radiology, ultrasound, and radiography, such as … Read more